Advisory Board

The advisory board of the Fraunhofer IBMT consists of high-quality doctors and scientists as well as decision-makers from industry and commerce, politics, local government, the respective current President of the University of Saarland. It advises the institute management and the executive board and makes an annual evaluation of the performance of the institute.

Members of the advisory board are:

Dr. Günter J. Bauer, CEO, Transimmune AG, Düsseldorf

Armin Engel, Consultant for Facility Management in Healthcare, Berlin

Dr. Christine Günther, Entrepreneur in Residence / Cell Therapy Evotec, Hamburg

Bernd Pfeil, Managing Director Future Electronics Deutschland GmbH, Aschheim

MinDirigin Dr. Susanne Reichrath, Delegate of the Prime Minister for Universities, Science and Technology, State Chancellery of Saarland, Saarbrücken

Prof. Dr. Manfred J. Schmitt, President of the University of Saarland, Saarbrücken

Dipl.-Ing. Otmar Peter Schön, Managing Director, Hydac Technology GmbH, Sulzbach/Saar (Chairman)

Dr.-Ing. Harald Stallforth, former Executive Vice President, Research & Development, Aesculap AG & Co. KG, Tuttlingen

Prof. Dr. Michael Stuke, former Max Planck Institute for Biophysical Chemistry, Laser Materials Processing, Göttingen

Dr. Hans-Ulrich Wiese, former Member of the Executive Board of the Fraunhofer-Gesellschaft, Munich

Honorary advisory board member since 2015: Prof. Dr. José G. Esparza-Bracho, University of Maryland, School of Medicine, former: Bill & Melinda Gates Foundation, Seattle, Washington, USA